General MedicationsORALStandard
MERCAPTOPURINE
MERCAPTOPURINE
Standard Dose
20MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview MERCAPTOPURINE is listed in Drugs@FDA under application 216418 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient MERCAPTOPURINE Form and strength SUSPENSION;ORAL - 20MG/ML Sponsor HIKMA Submission history Latest submission status date: 2025-02-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview MERCAPTOPURINE is listed in Drugs@FDA under application 216418 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MERCAPTOPURINE Form and strength SUSPENSION;ORAL - 20MG/ML Sponsor HIKMA Submission history Latest submission status date: 2025-02-26 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.